Introduction
Active immunisation with live rubella vaccine is carried out internationally. Extensive experience has so far shown that current rubella vaccines, particularly the Cendehill strain, are associated with a low incidence of adverse reactions, of which malaise, fever, rash, enlarged tender lymph nodes, arthralgia, and arthritis are the commonest.1-3 We have seen two patients who developed diffuse myelitis soon after receiving live rubella vaccine. Neither patient had any history to suggest the possibility of multiple sclerosis. 2) , and the CSF collected immediately before this procedure contained 2 x 103 lymphocytes/I, a protein concentration of 3-5 g/l, and normal glucose concentration. Bacterial culture of the CSF was negative. The CSF did not yield any viral growth in monkey kidney, continuous human cell line, and human amnion tissue cultures. Serum protein electrophoresis showed a normal pattern with a slight increase in y2-globulin. The haemagglutination titre against rubella was 1/256 one month and five months after vaccination. Complement fixation tests against several viral antigens showed no titres of significance. Coxsackie and echovirus titres were not sought. The patient was treated with a tailing course of corticosteroids over 10 weeks but there was little improvement in the neurological signs. Five years after she developed this illness there has been only a slight improvement in her neurological deficit.
Discussion
Neurological complications of immunisation with live rubella vaccine are uncommon. 4 Pain syndromes with abnormal nerve conduction responses, suggesting a polyneuropathy, have been described in 32 patients who underwent active immunisation with rubella vaccine. 4 Cooper et al reported paraesthesiae in 10 adults and two children and a "carpal tunnel syndrome" in a further adult.5 Tingling and itching sensations in the hands were noted in four patients after rubella immunisation, suggesting the presence of brachial neuritis.6 Only a weak neurotropic potential of attenuated rubella virus has been observed4-6; and even natural rubella is rarely associated with severe neurological complications. Acute encephalopathy may occur with an incidence of one case in 5000-6000 cases of wild rubella virus infection.7 8 Active immunisation with rubella vaccine has not been associated with severe neurological damage.
Although both our cases of severe neurological illness occurred shortly after rubella immunisation, this is not definite evidence of a causal relation. The two cases presented similar clinical findings and outcome, but there were several points of dissimilarity, including vaccination-illness interval, CSF findings, and myelographic appearances of the spinal cord. The differences tend to detract from the comparability of these two cases.
The latent interval of three days between vaccination and the onset of neurological disability in the second patient seems too short for a direct rubella virus invasion of the central nervous system, unless unidentified accelerating factors played a part. It has been shown that patients with congenital dysrhaphism may react adversely to smallpox vaccination.9 In a study of 109 cases of post-vaccine encephalitis from 107 families certain constitutional factors, including dysrhaphic stigmata, occurred with a higher incidence than in a control group of 102 random families.9 Our second patient had congenital dysplasia but its contribution to the sequence of events is not clear. Possibly paraplegia was part of the history of this patient's congenital dysplasia. The complex history and presence of congenital abnormalities in this patient make it difficult to firmly relate the vaccination to the development of paralysis. In the first patient an interval of three weeks between the administration of the epidural anaesthetic and the illness seems too long to implicate this procedure as a causative factor. No other complicating medical condition was present in the first case.
Diffuse myelitis occurring shortly after rubella immunisation has not been reported before. We cannot conclude that the neurological illnesses in these patients were directly attributable to the administration of live rubella vaccine, but the chronological relation between rubella immunisation and the development of transverse myelitis is of sufficient importance to report these case histories to encourage clinicians to report any similar experience.
